華檢醫療(01931.HK)擬出資6000萬元成立合營 投資IVD行業
格隆匯 8 月 3日丨華檢醫療(01931.HK)公告,於2020年8月3日,公司的全資附屬公司上海威士達(作為有限合夥人)與華佗(作為有限合夥人)、山東國惠(作為有限合夥人)及中民惠遠(作為普通合夥人)就成立專注於股權投資的合夥企業訂立合夥協議。合夥企業將擁有人民幣3億元資本承擔總額,上海威士達出資6000萬元。
於成立後,合夥企業將由上海威士達、華佗、山東國惠及中民惠遠分別擁有約19.99%、約29.99%、約49.99%及約0.03%權益。
合夥企業將根據合夥協議透過併購或其他形式的金融交易開展IVD行業的股權投資,專注於微生物學檢測、分子診斷及其他創新IVD技術產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.